Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by HervÃ© Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques FourniÃ© and FranÃ§ois RomagnÃ© on September 15, 1999 and is headquartered in Marseille, France.